ABOUT PHOTOCURE
NEWS
PRODUCTS
OUR TECHNOLOGY
R&D
INVESTORS
PRESS/MEDIA
Home
Contact
Sitemap
Search
NEWS
13.01.10:
Hexvix® receives reimbursement approval in Germany
06.01.10:
Inclusion completed in phase II study with Visonac™ for acne
06.01.10:
Financial calendar 2010
31.12.09:
Photocure received positive response from FDA on the New Drug Application (NDA) for Hexvix® for detection of bladder cancer
18.12.09:
FDA Advisory Committee voted favourably to Hexvix® application in USA
SHORTCUTS
Webcast presentation of 4th Quarter 2009 - 19. February at 11:30 CET
Annual report 2008
Press kit